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It is known that polysaccharides extracted from the Phellinus linteus (PL) mushroom possess antitumour activity. We previously have
demonstrated that high doses of PL render murine or human lung cancer cells susceptible to apoptosis. However, the molecular
mechanisms of PL-mediated apoptosis have not been fully explored. In this study, we demonstrate that LNCaP cells expressing the
androgen receptor (AR) are highly susceptible to apoptosis in response to treatment with high doses of PL. In this process, caspase 8
and its downstream effectors (such as BID), as well as ER stress-related, apoptotic signalling, are activated. In contrast, a moderate
amount of apoptosis occurs in PC3 cells (that lack AR) after the same treatment, which does not activate ER-mediated apoptotic
signalling. We also show that, in the process of PL-induced apoptosis, caspase 2 is induced in LNCaP cells, but not in PC3 cells.
However, LNCaP cells that express a mutated AR or LNCaP cells treated with a caspase 2 inhibitor blocked ER stress-induced
apoptotic signals. The magnitudes of the induction of apoptosis in these cells are comparable with what occurred in the PC3 cells.
The data demonstrate that high doses of PL activate the AR-dependent and independent apoptotic pathways. Our study also
suggests that caspase 2 is a key target in the determination of the susceptibility of prostate cancer cells to PL-induced apoptosis.
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Phellinus linteus (PL) is among a number of well-known medicinal
mushrooms from Asian countries, which have been taken orally
since ancient times as a health-promoting dietary supplement and
an adjuvant to combat viral and bacterial infections. PL, after
purification, shows a relatively homogeneous molecular weight
distribution on gel permeation HPLC and is estimated to be
around 150kDa from the retention time on HPLC pullulan
molecular markers (Song et al, 1995). The main components of
PL are polysaccharides (Song et al, 1995; Lorenzen and Anke, 1998;
Borchers et al, 1999; Han et al, 1999). Many studies demonstrated
that polysaccharides from various substances, including PL, are
remarkably effective in inhibiting the growth of tumours without
toxic side effects. Studies also showed that polysaccharides in PL
are able to suppress tumours, either indirectly by enhancing the
host’s immune system or directly by inducing apoptosis in tumour
cells (Chihara et al, 1969; Chung et al, 1982; Cun et al, 1994;
Wasser, 2002; Collins et al, 2006; Guo et al, 2006). Therefore, the
antitumour, antiangiogenic and immunomodulatory effects of PL
are potential areas for developing novel pharmaceutical products.
However, the underlying molecular mechanisms of the antitumour
effects of PL have not yet been fully explored.
Changes in the androgen receptor (AR) have been indicated to
contribute to the development of prostate cancer and are a serious
challenge to effective treatment. Mutations in the AR can increase
its affinity for ligand binding, permitting activation by non-
androgenic hormones or even antagonists (Nelson et al, 2003;
Debes and Tindall, 2004). Overexpression of AR increases the
sensitivity of prostate cancer cells to low levels of androgens, which
promotes androgen-independent growth (Linja et al, 2001; Chen
et al, 2004; Debes and Tindall, 2004). Studies also showed that AR,
as a crucial factor, determines the molecular alterations required
for the development of refractory prostate cancer (Debes and
Tindall, 2004). In general, the AR is bound to heat shock proteins,
in the cytoplasm. Upon binding to the active androgen dihydro-
testosterone (DHT), the receptor dissociates from the heat shock
proteins, and translocates to the nucleus (Feldman and Feldman,
2001; Grossmann et al, 2001; Chen et al, 2004). In the nucleus, AR
dimerises and binds to androgen-response elements to initiate the
transcription of genes required for growth. With the progression of
the degree of the malignancy, prostate cancer loses expression of
AR and abrogates the hormone dependency. These observations
indicate that a major challenge in the treatment of prostate cancer,
especially the hormonally refractory form, is to understand the
genetic and cellular alterations associated with the susceptibility of
prostate cancer to apoptosis. We have demonstrated that PL, at low
doses, can synergize with doxorubicin (an anticancer drug) to
induce apoptosis in LNCaP cells (Collins et al, 2006). However, it is
not clear how PL transmits apoptotic signals in these cells.
Apoptosis can be triggered by a variety of internal or external
signals. Caspases, a highly conserved family of cysteine proteases,
are key apoptotic effectors and play a critical role in apoptosis
through a cascade of cleavage events (Schmitz et al, 2000; Shi,
2002). Caspases exist as dormant proenzymes in cells and are
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sactivated through proteolysis. Upon apoptotic stimulation, cleaved
caspase 8, as an initiator, leads to the activation of immediate
downstream effector caspases 3 and 7, resulting in BID cleavage and
cytochrome c release (Thornberry et al, 1997; Bhornberry and
Lazebnik, 1998). The release of cytochrome c from the mitochondria
to the cytosol causes the formation of the apoptosome, followed by
activation of caspase 9, which, in turn, results in a caspase chain
reaction (Susin et al, 1999). Among caspase family members,
caspase 2 is unique because it has features of both the long
prodomain of upstream caspases and the optimal recognition motif
of downstream caspases (Harvey et al, 1997; Droin et al,2 0 0 1 ) .T h e
prodomain is essential for the dimerisation and autoprocessing of
precursor caspase 2, which allow caspase 2 to be directly activated
and further initiate the caspase cascade in response to various
apoptotic stimuli (Harvey et al, 1997; Droin et al,2 0 0 1 ) .
The endoplasmic reticulum (ER) is the main intracellular
organelle in charge of proper folding and maturation of
transmembrane and secretory proteins (Kaufman 1999; Patil and
Walter, 2001; Demaurex and Distelhorst, 2003). Studies have
demonstrated that the ER functions as a sensor of cellular stress to
maintain homeostasis in cells (Ma and Hendershot, 2001, 2004;
Rutkowski and Kaufman, 2004; Schroder and Kaufman, 2005). De-
regulation of ER functions is often associated with diseases ranging
from diabetes to neurodegenerative illnesses (Forman et al, 2003;
Takuma et al, 2005). ER stress can cause changes in intracellular
calcium levels, nutrient deprivation altered glycosylation or lipid
overload (Ma and Hendershot, 2001, 2004; Rutkowski and
Kaufman, 2004; Schroder and Kaufman, 2005). To compensate
for ER stress, the unfolded protein response is activated in cells,
during which the expression of certain proteins resident in the ER
(such as BiP or ATF-4) is elevated (Ma and Hendershot, 2004;
Sriburi et al, 2004). Persistent protein overload in the ER can
trigger apoptosis (Herr and Debatin, 2001; Breckenridge et al,
2003). Damage to the ER activates certain caspase family members,
including caspase 2 (Morishima et al, 2002; Chae et al, 2004).
Previous studies, including ours, demonstrated that PL pos-
sesses antitumour properties (Chihara et al, 1969; Chung et al,
1982; Cun et al, 1994; Wasser 2002; Collins et al, 2006; Guo et al,
2006). We recently reported that PL, at low doses, can sensitise
prostate cancer cells for cytotoxicity induced by anticancer drugs
(such as doxorubicin) (Collins et al, 2006). We also showed that
high doses of PL can elicit apoptosis in mouse and human lung
cancer cells (Guo et al, 2006). In the present study, we further
investigated the molecular mechanisms of PL-mediated apoptosis
in prostate cancer cells. LNCaP cells express the AR; PC3 cells do
not. We demonstrated that high doses of PL could induce large
numbers of LNCaP cells to undergo apoptosis, whereas the
magnitude of apoptosis in PC3 cells was moderate. During
the process of PL-induced apoptosis, caspase 8 and its downstream
effectors (such as caspase 3 and BID) were cleaved and further
activated in LNCaP and PC3 cells. However, the expression of
caspase 2 was elevated in LNCaP cells only, but not in PC3 cells. ER
stress-related apoptotic signals were also activated in LNCaP cells.
ER-mediated apoptosis was blocked by the addition of caspase 2
inhibitor to LNCaP cells as well as abolished in a strain of LNCaP
cells expressing a mutated AR. Our study implies that high doses
of PL are able to elicit multiple apoptotic signalling pathways in
prostate cancer cells, and that caspase 2, acting downstream of the
AR, sensitises prostate cancer cells to PL-induced apoptosis.
MATERIALS AND METHODS
Cells and reagents
Phellinus linteus powder was purchased from Panbio-Tech (Taejon,
South Korea) and purified using ethanol precipitation methods
followed by DEAE-cellulose and gel permeation chromatography
(Song et al, 1995). The purified components of PL consist mostly of
polysaccharides. The media for cell culture including DMEM,
antibiotics (penicillin and streptomycin) and trypsin-EDTA were
purchased from Invitrogen (Carlsbad, CA, USA). Antibodies were
purchased from Pharmingen (Palo Alto, CA, USA). Human prostate
cancer cell lines LNCaP and PC3 were purchased from American
Type Culture Collection (Manassas, VA, USA) and were cultured in
Dulbecco’s modified Eagle’s medium supplemented with 10% heat-
inactivated fetal calf serum, 2mML-glutamine, 100Uml
1 of penicillin
and 100gml
1 of streptomycin. Normal human prostate epithelial
PrEC cells (Cambrex, NJ, USA) were cultured in the PrEGM medium
(Cambrex, NJ, USA). All the antibodies used were purchased from BD
Biosciences (San Diego, CA, USA). The caspase 2 inhibitor was
purchased from Calbiochemical (San Diego, CA, USA).
Luciferase assay
Cells were cotransfected with 15mg of the luciferase construct and
2mgo fb-gal (an internal control). Forty-eight hours later, the cells
were grown in Charcol medium for 6h and stimulated with DHT.
Subsequently, the luciferase activity was analysed.
DNA fragmentation analysis
A flow cytometric analysis was performed using a FACScan
(Becton Dickenson, Mountain View, CA, USA). The data analysis
was performed using the Cell-Fit software program (Becton
Dickenson). Cell-Fit receives data from the flow cytometer and
provides real-time statistical analysis, computed at 1 s intervals,
and also discriminates doublets or adjacent particles. Cells with
subG0–G1 DNA contents after staining with propidium iodide
were counted as apoptotic cells. In brief, 48h following the
treatment, the cells were harvested by trypsinisation, washed with
1 cold PBS and then fixed in 70% cold ethanol. Afterwards, the
cells were stained with 0.1mgml
1 propidium iodide containing
1.5mgml
1 RNase. Following incubation at room temperature for
2h, the DNA contents of the cells were tested by a Becton
Dickinson FACScan machine (BD Biosciences) and evaluated with
BD FACStation software CellQuest.
Annexin V assay
Following treatments, cells (110
6) were washed twice with cold
PBS and stained with Annexin V-FITC using the Annexin kit (BD
Biosciences) to detect apoptotic cells using a flowcytometer.
Immunoblot analysis
After lysing cells in lysis buffer (150mM NaCl, 0.1% Nonidel P-40,
0.1% SDS, 50mM Tris, 50mgml
1 phenylmethylsulfphonyl fluoride,
10mgml
1 aprotinin, 5mgml
1 leupeptin, 0.1mgml
1 NaF), whole-
cell lysates containing equal amounts of total proteins were prepared
and separated on an SDS–PAGE gel. Subsequently, proteins were
blotted to a nitrocellulose membrane. After blocking the membrane
in the blocking solution (5% non-fat milk in 1TBS-T (10mM Tris-
HCl, pH 8.0, 150mM NaCl and 0.05% Tween20)) for 1h at room
temperature, immunoblotting was performed. The proteins of
interest were detected by autoradiography after treating the
membrane with Western lightning Western blot chemiluminescence
reagent (Perkin Elmer Life Sciences, Boston MA, USA). The
membranes were stripped and re-probed with a b-actin antibody
to ensure equal loading of proteins. Each immunoblot analysis was
repeated more than once to ensure reproducibility.
Caspase activity analysis
Caspase 8 and 2 colorimetric assay kits (Bio Vision) were used to
measure the activities of caspase 8 and 2 in cell lysates. The assays
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sare based on spectrophotometric detection of the chromophore p-
nitroanilide (pNA) after cleavage from the labelled substrate IETD-
pNA for caspase 8 or VDVAD-pNA for caspase 2. The pNA light
emission is quantified using a spectrophotometer. Briefly, cells
(0.510
6), with or without treatment with PL, were lysed in 1%
Triton X-100 buffer (pH 7.2) containing protease inhibitors and
subsequently subjected to the assay.
Soft agar assay
Petri dishes were first layered with 0.6% basal agar dissolved in
DMEM medium containing 10% fetal calf serum. Cells were mixed
in 0.33% agar dissolved in DMEM medium containing PL
(1mgml
1). The plates were incubated at 371C in a humidified
atmosphere for 14 days. Fresh medium (2ml) containing PL was
added to the cultures every 3 days.
Statistics
Means and standard deviations of the results of the experiments
were computed. Standard deviations are displayed as error bars in
the figures.
RESULTS
Different susceptibilities of LNCaP and PC3 Cells to
apoptosis induced by PL mushroom
It is known that PL possesses antitumour properties, which have
been linked to its polysaccharide content (Song et al, 1995). We
recently demonstrated that PL, at low doses (o0.5mgml
1),
synergises with doxorubicin (an anticancer drug) to induce
apoptosis in prostate cancer LNCaP cells (Collins et al, 2006). To
explore the molecular mechanisms of PL-induced apoptosis and
the effect of the AR on this process, human prostate epithelial
PrEC cells and prostate cancer LNCaP and PC3 cells were used.
The functionality of AR in the cells was first confirmed using a
luciferase assay. A construct containing the AR responsive element
fused with luciferase was transiently transfected into PrEC, LNCaP
and PC3 cells, and the luciferase activity was assayed after DHT
treatment (Figure 1A). AR on the surface of PrEC and LNCaP cells,
but not PC3 cells, was responsive to DHT. The ability of PL at high
doses (0.75 and 1mgml
1) to induce apoptosis was then tested
(Figure 1B). Forty-eight hours after PL treatment, a DNA
fragmentation assay was conducted. A few untreated PrEC, LNCaP
or PC3 cells had fragmented DNA. A large number of LNCaP cells
and a lesser amount of PC3 cells underwent PL-induced apoptosis
in a dose-dependent fashion. However, very few PrEC cells
underwent apoptosis in response to the treatment, which is
consistent with our previous observation that PL has little toxicity
on normal cells (Song et al, 1995; Guo et al, 2006). To further
confirm the occurrence of apoptosis induced by high doses of PL,
an Annexin V assay was conducted (Figure 1C), and similar results
were obtained. Overall, the results suggest that AR might be a
factor in the regulation of the susceptibility of prostate cancer cells
to PL-induced apoptosis.
Next, we performed a soft agar assay to determine whether PrEC
cells resemble normal, non-transformed cells, and if high doses of
PL are able to kill prostate cancer cells and prevent them from
forming colonies in soft agar (Table 1). PrEC cells did not form
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Figure 1 AR function and PL-mediated DNA fragmentation. (A) PrEC, LNCaP and PC3 cells were cotransiently transfected with an AR-responsive
element-luciferase and b-gal (internal control) constructs. Forty-eight hours post-transfection, cells were cultured in the medium without growth factors for
6h and stimulated with DHT for 24h. Subsequently, luciferase activity was analysed. Error bars represent the standard deviation over five independent
experiments. (B) The cells were treated with different doses of PL for 48h, and the percentage of the cells with fragmented DNA was analysed by a flow
cytometer. Error bars represent the standard deviation over five independent experiments. (C) After treatment with PL, the percentage of the cells stained
with Annexin V was measured.
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scolonies in soft agar. In comparison, untreated LNCaP or PC3 cells
formed colonies in soft agar medium. The numbers of colonies
generated from PC3 cells were higher than those from LNCaP cells,
indicating that PC3 cells are more malignant. However, the
addition of PL dramatically reduced the ability of LNCaP cells to
form colonies in a dose-dependent manner. The same doses of PL
only moderately prevented PC3 cells from forming colonies. The
results further suggest that PL, at high doses, induces apoptosis
and blocks prostate cancer growth.
Caspases 8/3 and BID are activated in LNCaP and PC3 cells
in response to high-dose PL treatment
Caspase family members are important factors in the induction of
apoptosis triggered by various apoptotic stimuli (Schmitz et al,
2000; Shi, 2002). The activation of caspases involves a series of
protein cleavages resulting in small, active fragments for initiating
apoptosis (Thornberry et al, 1997; Bhornberry and Lazebnik,
1998). Caspase 8 has been shown to be one of the initiators of the
caspase cascade (Thornberry et al, 1997; Bhornberry and Lazebnik,
1998). We tested whether caspase 8 is activated by high doses of PL
in LNCaP and PC3 cells. Immunoblot analysis was conducted to
detect the existence of the cleaved, active p17 fragment of caspase 8
(Figure 2A). The active fragment of caspase 8 was not revealed by
anti-caspase 8 Ab in PrEC cells with or without PL treatment.
Caspase 8 also could not be detected in untreated LNCaP and PC3
cells. In contrast, the active form of the protease was present in
treated LNCaP cells, and present in lesser amounts in PC3 cells. To
further confirm the activation of caspase 8 induced by PL, the
enzymatic assay of caspse 8 was analysed (Figure 2B). The results
were consistent, in that caspase 8 activity, after PL treatment, was
higher in LNCaP cells than that in PC3 cells, and was undetectable
in PrEC cells.
Caspase 3 and BID are the downstream effectors in the caspase
8-mediated cascade (Thornberry et al, 1997; Bhornberry and
Lazebnik, 1998). The status of these caspase family members,
following treatment with high doses of PL, was examined by
immunoblot analysis (Figure 2C and D). The active form of
caspase 3 and the cleaved fragment of BID were not seen in
untreated LNCaP or PC3 cells, but were revealed by the
corresponding antibodies in both cell lines treated with 1mgml
1
of PL. The results indicate that caspase 8 and its downstream
effectors participate in PL-induced apoptosis in prostate cancer
cells, whether they express AR or not.
Caspase 2 is upregulated in LNCaP but not in PC3 Cells
after treatment with high doses of PL
From the analysis of its primary structure, caspase 2 contains a
long NH2-terminal prodomain, which is used by apoptotic stimuli
to initiate apoptosis, and an optimal recognition motif of
downstream caspases to execute apoptotic processes (Harvey
et al, 1997; Droin et al, 2001). To further search for the cause of the
different sensitivities of LNCaP and PC3 cells to PL-induced
apoptosis, the expression of caspase 2 was examined by
immunoblotting (Figure 3A). A baseline expression of caspase 2
was detected by anticaspase 2 Ab in untreated LNCaP cells, and the
levels of the protease were significantly increased after treatment
with high doses of PL in a dose-dependent manner. However, the
baseline expression of caspase 2 in PC3 cells did not change after
PL treatment. The activity of caspase 2 after PL treatment was also
tested by the enzymatic assay (Figure 3B). The activity of caspase 2
was dramatically induced by PL in LNCaP cells but not in PC3
cells.
The unfolded protein response occurs in ER stress-induced
apoptosis and is reflected by increases in ER proteins (Patil and
Walter, 2001). ER stress-induced apoptosis has been demonstrated
to be regulated in part by caspases (Morishima et al, 2002; Chae
et al, 2004). As caspase 2 is differentially expressed in LNCaP and
PC3 cells, we tried to determine whether caspase 2, through the ER,
is sensing PL treatment. We first tested the expression of ER
proteins, such as BiP and ATF-4, by immunoblotting (Figure 4). A
baseline level of BiP expression was detected in untreated LNCaP
cells, and this ER protein was induced by PL (Figure 4A). In
comparison, PL had no effect on BiP expression in PC3 cells. The
same expression patterns of ATF-4 were obtained from LNCaP and
PC3 cells (Figure 4B). The data suggest that high doses of PL
elicited the unfolded protein response in the cells expressing AR,
but not in those without a functional AR.
Effect of AR or caspase 2 on PL-induced apoptosis
It has been reported that the AR, by repressing the cis-element of
the caspase 2 promoter, regulates caspase 2 expression (Rokhlin
et al, 2005). Our results presented above indicate the involvement
of AR or caspase 2 in PL-induced apoptosis in LNCaP cells. To test
the linear relationship between these two molecules under such
apoptotic conditions, an LNCaP cell line that possesses a non-
functional AR was employed. After treatment of LNCaP and its
mutant cells with 0.75 or 1mgml
1 of PL, a DNA fragmentation
assay was conducted (Figure 5A, upper panel). LNCaP cells
underwent apoptosis after PL treatment in a dose-dependent
fashion. The magnitude of apoptosis induced by PL was notably
lower in the LNCaP mutants than in the wild-type cells. An
Annexin V assay was also performed, and similar results were
obtained (data not shown). Furthermore, the expressions of BiP
and ATF-4 were examined by immunoblot analysis (Figure 5A,
lower panel). The ER proteins were induced by PL in LNCaP cells
but not in the mutant cells. The data indicate that AR is an
important regulator in apoptosis and is induced by high doses of
PL.
Next, we tested the effects of a caspase 2 inhibitor on PL-induced
apoptosis. LNCaP, mutant LNCaP and PC3 cells were treated with
a caspase 2 inhibitor before the high-dose PL treatment.
Subsequently, the percentage of DNA fragmentation was measured
(Figure 5B). The magnitude of PL-induced apoptosis in LNCaP
cells was partially suppressed in the presence of the caspase 2
inhibitor, which is similar to what occurs in PL-treated PC3 cells.
In comparison, the inhibitor had a minimal effect on apoptosis
induced by PL in PC3 or mutant LNCaP cells. An Annexin V assay
was also performed and similar results were obtained (data not
shown). The expressions of BiP and ATF-4 were tested with or
without the addition of a caspase inhibitor in LNCaP or mutant
LNCaP cells by immunoblotting (Figure 5C). The inhibitor blocked
the expressions of these ER-stress proteins in LNCaP cells. Overall,
the data suggest the existence of a linear relationship between AR
and caspase 2 in response to PL treatment, which sensitises ER-
regulated apoptotic signalling.
Table 1 Colony formation of PrEC, LNCaP and PC cells in soft agar in
the presence of PL
Cell types Treatment No of colonies s.d.
PrEC No treatment 0 70
LNCaP No treatment 154 77.5
LNCaP PL (0.75mgml
1)1 774
LNCaP PL (1.0mgml
1)5 72
PC3 No Treatment 208 71.8
PC3 PL (0.75mgml
1) 106 78
PC3 PL (1.0mgml
1)6 8 75
The cells were cultured in soft agar in the absence or presence of different
concentrations of PL for 2 weeks. Every 3 days, fresh growth medium containing PL
was added into the cultures. s.d.: standard deviation over five independent
experiments.
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sDISCUSSION
The major findings in our current study are that high doses of PL
elicit two major apoptotic pathways in prostate cancer cells: a
caspase 8-induced cascade and the unfolded protein response. The
activation of caspase 8 and its downstream effectors may be a
general effect of PL on tumours. The unfolded protein response in
the ER appears to be prostate cancer specific, and is regulated by
the AR and caspase 2. Our study suggests a molecular target of PL,
which provides a better understanding of the potential of PL to
treat prostate cancer.
It is known that PL is not toxic in general (Song et al, 1995). We
have demonstrated that PL, at high doses, causes lung epithelial
cells to arrest in the G1 phase of the cell cycle by blocking the
expression of cyclin D1 and its further interaction with cell cycle-
dependent kinases 4 and 6 (Guo et al, 2006). It is possible that
treatment with PL elicits G1 checkpoint control in normal prostate
epithelial cells, such as PrEC, resulting in the cessation of cell cycle
progress. In tumour cells, cell cycle checkpoints are often
impaired. Under such conditions, high doses of PL become
apoptotic and activate the cell death programme in prostate cancer
cells.
It has been reported that caspase 2 expression is regulated by the
AR. As an unusual member of the caspase family, caspase 2
possesses features that can both initiate and execute programmes
of cell death (Harvey et al, 1997; Droin et al, 2001). Activation of
caspase 2 results in a complex that consists of the death-domain-
containing protein and the adapter protein. It has also been shown
that activated caspase 2 can directly cause the cleavage of BID
(Harvey et al, 1997; Droin et al, 2001). In addition, studies have
demonstrated that caspase 2, upon different apoptotic stimula-
tions, re-distributes to the nuclei or other subcellular membrane
compartments to participate in the execution of the cell death
programme (Mancini et al, 2000; Chae et al, 2004; Rokhlin et al,
2005). Our results here demonstrate the interconnection between
AR and caspase 2 in the regulation of PL-induced apoptosis in
prostate cancer cells. Studies to identify molecular targets in the
cooperation between AR and caspase 2 during PL-induced
apoptosis are under way.
In the progression of prostate cancer, AR is often mutated or its
expression is lost, which plays an important role in the
development of the resistance of cancer cells to treatment.
Therefore, the discovery of molecular targets to sensitise apoptotic
signalling pathways has important therapeutic implications.
A
Caspase 8 (p17)
Actin
Caspase 8 (p55)
Caspse 8 (p53)
0 0.75 mg ml−1 0.75 mg ml−1 0.75 mg ml−1 1.0 mg ml−1  1.0 mg ml−1  1.0 mg ml−1  0
LNCaP PC3
0P L
PrEC
0
1000
2000
3000
4000
5000
6000
p
N
A
 
a
b
s
o
r
b
a
n
c
e
Control
PL (1.0 mg ml−1)
PrEC PC3 LNCaP
B
Actin
cleaved BID
LNCaP PC3
D
C
Cleaved caspase 3
Actin
0 1.0 mg ml−1 0 1.0 mg ml−1 PL
Figure 2 Activation of caspase 8, caspase 3 and BID in response to treatment with PL. (A) After treating with different concentrations of PL, cell lysates
from PrEC, LNCaP and PC3 cells were prepared. Expression of the activated form of caspase 8 was determined by Western blot. Equal loading of total
proteins was verified by b-actin expression. (B) After PL treatment, cell lysates were prepared to analyse caspase 8 activity (B–D). Following the
treatments, lysates were prepared to analyse the presence of the cleaved, active forms of caspase 3 or BID. Equal loading of total proteins was verifiedb yb-
actin expression.
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sGenetic targeting or pharmacological manipulation of caspase
family members and their regulators/modulators would provide
better clinical strategies. It has been shown that overexpression of
caspase 7 in LNCaP cells could effectively induce apoptosis, and
this has been very promising clinically (Marcelli et al, 1999). Our
present study indicates that caspase 2 is an intracellular target for
upregulating the susceptibility of PC3 cells or prostate cancer cells
containing a mutated AR to PL-induced apoptosis.
Activation of caspase family members is at the core of apoptosis,
representing a point of intersection of various apoptotic pathways.
Tumour necrosis factor or Fas/CD95 receptors, mitochondrial
proteins (such as cytochrome c) and granzyme are able to induce
cell death through activation of the caspase cascade (Schmitz et al,
2000; Shi, 2002). Damage to or stress in the ER or Golgi has been
shown to be able to trigger apoptosis (Herr and Debatin, 2001;
Breckenridge et al, 2003). Studies have shown that the unfolded
protein response or lack of calcium is responsible for ER-mediated
apoptosis (Breckenridge et al, 2003). ER stress has been
demonstrated to cause the translocation of certain caspases to
the ER or Golgi and the execution of apoptosis there. Calcium
released from the ER during times of ATP deficiency is an
important element in apoptosis induced by ischaemia–reperfusion
injury. It is possible that PL treatment upregulates and activates
caspase 2 that subsequently translocates to the ER and causes the
unfolded protein response, resulting in apoptosis.
Caspases 8, 6 and 3 are major players in caspase-induced
apoptosis (Nicholson and Thomberry, 1997). We demonstrated
that PL, at low doses, is able to synergise with anticancer drugs
(such as doxorubicin) for the induction of apoptosis in LNCaP
cells (Collins et al, 2006). We also demonstrated that high doses of
PL elicit a caspase cascade in human and murine lung cancer cells,
but not in normal lung epithelial cells, in which caspase 3, caspase
8 and BID are activated (Guo et al, 2006). In this study, we further
demonstrate that treatment with high doses of PL can activate
caspase 8-initiated apoptotic signalling in both AR-expressing
(LNCaP) and AR-null (PC3) prostate cancer cells. It seems that the
high doses of PL, by activating the caspase 8-regulated signalling
pathway, are generally toxic to various types of tumours and have
no effect on normal cells.
The successful treatment of prostate cancer requires identifica-
tion of specific intracellular targets for sensitising the tumour to
apoptosis. Our previous study demonstrated that PL, at low doses,
acts as an enhancer to sensitise anticancer drug-mediated,
apoptotic signalling, and this sensitization can be obtained at
subtoxic concentrations of the drug. In this study, we showed that
high doses of PL can mobilize multiple apoptotic signalling
pathways to cause different degrees of cytotoxic effects on prostate
cancer cells, depending on the expression of AR. We also conclude
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Figure 3 Caspase 2 activation in response to different doses of PL treatment in prostate cancer cells. (A) After treating LNCaP and PC3 cells, cell lysates
were prepared and subsequently analysed for the expression of caspase 2. Equal loading of total proteins was verified by b-actin expression. (B) After PL
treatment, cell lysates were prepared to analyse caspase 2 activity.
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Figure 4 Expression of the ER proteins BiP and ATF-4 in PL-treated
prostate cancer cells. LNCaP and PC3 cells were untreated or treated with
1mgml
1 of PL for 24h and lysates were prepared. Subsequently,
immunoblotting was conducted to detect BiP (A) and ATF-4 (B)
expression. Equal loading of total proteins was verified by b-actin
expression.
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Figure 5 Effect of mutant AR or caspase 2 inhibitor on PL-induced apoptosis. (A) After treating LNCaP or LNCaP cells expressing a mutated AR with
different doses of PL, the percentage of DNA fragmentation was measured by a flow cytometer (upper panel). The lysates from untreated or treated cells
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sthat caspase 2, in an AR-dependent fashion, may be a specific
intracellular switch for the regulation of the susceptibility of
tumour cells. Our data suggest that PL, by modulating caspase
activity, can be developed for more efficient therapies against
refractory prostate cancer.
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